31st Annual North American Cystic Fibrosis Conference

S08 - S08: APP&D: New Treatment Strategies Focused on Abnormal Mucus

Nov 3, 2017 10:30am ‐ Nov 3, 2017 11:55am


Description

This symposium aims to provide insights into the abnormal properties of CF mucus and explore different therapeutic approaches for CF lung disease. New data from recent clinical studies offer unique perspectives on the pathological changes in CF mucus related to hydration, pH and viscoelasticity. This symposium will focus on basic findings and recent efforts towards translating these advances into novel therapies.

Learning Objectives:

  1. Identify the basic defects of CF mucus responsible for impaired mucociliary clearance.
  2. Discuss the different therapeutic approaches that address mucus clearance defects in CF.
  3. Evaluate drug efficacy and tolerability tested in experimental models and in CF patients.

Symposium Chair(s):

Symposium Speaker(s):

  • Jane Davies, M.D., MBChB, MRCP, Prof - Paed Respirology & Experimental Medicine
  • John Fahy, M.Sc., M.D., UCSF Medical Center
  • Marcus Mall, M.D., Professor
  • David Stoltz, M.D., Ph.D., Professor, Univ. of Iowa Hospital & Clinics

You must be logged in and own this session in order to post comments.